Spain's Grifols to dismiss more than 2,000 US employees in $427M cost savings bid
Many biotechs and pharmas have had to pull out the budget axe in a bid to cut costs this year — and now a major Spanish company is joining their ranks.
The pharma and blood and plasma giant Grifols put out word Wednesday that it will lay off more than 2,000 employees in the US as part of a three-pronged savings plan, estimated to save the company around $427 million. Some of those savings will be seen in 2023, and the rest the following year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
